Latest Capital Raises News

Desert Metals has expanded its Tiogo gold anomaly at Tengrela South, Côte d'Ivoire, by over 3km northwards, unveiling a new high-priority target ready for drilling.

MetalsGrove Mining has identified extensive gold anomalous trends spanning 18km at its Zuénoula permit, setting the stage for multiple drill targets as soil sampling and assay results advance.

Pacific Edge reported a steep 47% revenue drop in FY26 following Medicare coverage loss but secured a draft Medicare policy covering its Cxbladder tests and raised NZ$25.4 million to fuel growth and commercial execution.

Radius Residential Care has syndicated its bank debt, boosting facility limits by NZD 30 million and cutting financing costs by 65 basis points to support its growth plans, including a new care home acquisition and development projects.

TruScreen Group has secured NZ$1.82 million through an oversubscribed placement, underscoring investor confidence amid its global cervical screening expansion. The company also announced a renounceable rights issue and attaching options, both subject to shareholder approval.

Alternative Investment Trust (AIQ) has issued 7.39 million units at A$1.38 each, raising A$10.2 million from wholesale investors without a product disclosure statement. The capital raise aligns with AIQ’s adjusted net tangible asset value and complies with Corporations Act requirements.

Vectus Biosystems has secured $791,000 through a placement to accelerate its lead fibrosis drug VB0004's Phase IB clinical trial and advance other drug candidates.

1414 Degrees Limited has responded to an ASX price query after its shares jumped from $0.056 to $0.097 in days, confirming no undisclosed information but highlighting progress in aerospace and energy projects.

Orion Minerals has secured $15.4 million in a placement to accelerate development at its Prieska and Okiep copper projects in South Africa, paving the way for its transition to a copper producer.

Ballymore Resources has pushed the boundaries of its Torpy’s silver-lead-zinc-indium discovery in North Queensland, with initial results from a fresh 3,000m drilling campaign revealing broad zones of massive sulphide mineralisation closer to surface. Assays are due in June, while a government-backed gravity survey aims to unlock further targets across the Ruddygore corridor.

TrivarX has contracted Beyond Drug Development to drive its Stabl-Im MRI imaging platform into Phase 1 trials, aiming to start safety testing in healthy volunteers by late 2026.

Godolphin Resources is spinning out its Narraburra Rare Earths Project into a new ASX-listed entity, Matrix Critical Minerals, with MST Financial appointed to spearhead the IPO expected in the second half of 2026.